I'm a pharmacokineticist focused on the experimental therapeutics of anticancer drugs. In particular we are interested in using pharmacokinetic [PK] and pharmacodynamic [PD] approaches to advance drug development and improve drug therapy. Currently, these efforts are directed towards experimental models of brain tumors. We hope to identify new chemotherapeutic strategies that are derived from tumor-directed PK/PD investigations and enhance the translational foundation of preclinical to clinical research.
 
At Mount Sinai, I plan to continue my work on the experimental therapeutics of brain tumors, and hope to establish new collaborations in anticancer drug therapeutics and PKs and PDs.